William Dai

Managing Partner at ShangBay Capital

Palo Alto, California

Overview

William Dai is the Founding Managing Partner at ShangBay Capital in Palo Alto, California, where he has successfully invested in companies like Avation Medical and Laplace Interventional. With a strong background in venture capital and mergers, he has served on the boards of various medical device and healthcare companies, showcasing his expertise in strategic business development and finance. As the Founding Managing Partner at ShangBay Capital, William Dai has overseen successful investments in a variety of sectors, including medical devices and digital health, and has demonstrated a keen ability in financial modeling and corporate development. His extensive experience in venture capital and mergers, coupled with his role on multiple company boards, highlights his strategic prowess and impact in the industry.

Work Experience

ShangBay Capital

Founding Managing Partner
2015 - Current
Founding Managing Partner
2015

Best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early sta

shangbaycapital.com

Luminopia Inc.

Board Member
2022

YorLabs

Board Member
2021

True to life: setting a new standard in intracardiac image guided therapy

Raised $35,162,235.00.

yorlabs.com

Laplace Interventional

Board Member
2021
Healthcare

Laplace is a medical device company that develops transcatheter tricuspid valve technology.

Raised $20,800,000.00 from Shangbay Capital, JWC Ventures, Features Capital and Engage Venture Partners.

SetPoint Medical

Board Member
2020

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

Raised $344,000,000.00 from Citta Capital, SVE Capital, Shangbay Capital, Gilmartin Capital LLC, New Enterprise Associates, Boston Scientific, Action Potential Venture Capital, Richard King Mellon Foundation and Euclidean Capital.

setpointmedical.com